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I. NTTRODUCTIONI
American consumers are currently at the leading edge of what
promises to be a wave of foods modified through the use of modem
recombinant DNA technologies.2 In the years since the introduction of
the "Flaw Savr" tomato,3 biotechnology companies continue to
introduce genetically engineered agricultural products to consumers at
the supermarket. There are currently eleven such agricultural products
on grocer's shelves, with an additional twenty-nine currently awaiting
approval or under development.4 For example, an estimated thirteen to
sixteen percent of the American soybean crop is currently produced from
* J.D. Candidate 2000, University of San Diego School of Law.
1. My thanks to A. Rai for her advice in preparing this Comment, and to M. De
Anney for his editorial suggestions. This Comment is dedicated to Ann Whittaker and
to the memory of Richard Whittaker, my parents.
2. "Recombinant DNA technologies" refers to the techniques used by scientists to
transfer discrete pieces of genetic material into a recipient plant, animal or
microorganism. See STRATEGIES FOR ENGINEERING ORGANISMS (A.T.H. Burns ed.,
Butterworth-Heinemann, Ltd. 1993).
3. Calgene's Flavr Savr tomato was the first widely available food produced
using recombinant DNA techniques. Introduced in November of 1993, first year sales
were $14 million out of a total market for tomatoes of $4 billion. See Greg Beaubien,
Genetic Growth Lab Work is Debated, CHATrA OOGA TIMES, Sept. 19, 1996, at Fl.
4. See Marian Burros, Eating Well, N.Y. TIMES, May 21, 1997, at B8. Those
genetically engineered foods already in the market include abalone, canola oil, catfish,
chymosin, corn, cottonseed oil, potatoes, prawns, salmon, soybeans, and tomatoes.
Those genetically engineered foods under development include alfalfa, apples,
asparagus, barley, beets, broccoli, carrots, cauliflower, chestnuts, chicory, cucumbers,
flaxseed, grapes, kiwi, lettuce, melons, papayas, peanuts, pepper, raspberries, rice,
squash, strawberries, sugar cane, sunflowers, sweet potatoes, walnuts, watermelons, and
wheat. See id.
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genetically engineered seeds.5 This figure is expected to rise to forty
percent by 1998. With approximately seventy percent of processed
foods containing soy protein, the exposure of American consumers to
genetically engineered foods is pervasive.7  Given the pace of
development, this exposure will probably continue to increase.
Consumers, however, lack the ability to control the extent of their
exposure, because current U.S. Food and Drug Administration (FDA)
regulations do not consider recombinant DNA technologies to be
fundamentally different from traditional agricultural breeding
techniques, and therefore do not require any labeling of genetically
engineered foods.8 Not surprisingly, consumer advocates disagree with
the FDA's decision and question the safety of growing and consuming
these novel foods. As a result, various groups are pressing for some
form of labeling of genetically engineered foods.
This Comment argues that the FDA must reconsider its position on the
labeling of genetically engineered foods. There is no doubt that genetic
engineering of food promises a number of significant benefits to both the
consumer and the farmer, and has become a permanent part of the food
supply. But recent research points out that these benefits do not come
without significant risks, both to the consumer and to the environment.
A federal requirement that genetically engineered foods be labeled as
such is a necessary step to promote confidence in the American
consumer in the face of unease over these very real risks.9 Moreover, in
the absence of a federal labeling standard, individual states have the
power to impose their own labeling standards. A federal labeling
standard is thus necessary to occupy the field and prevent any disruption
in the national food marketplace due to a proliferation of differing state
labeling standards. Finally, international initiatives for labeling
genetically engineered foods are proceeding much more rapidly than are
United States national labeling initiatives. A federal labeling standard is
required to provide leadership to a global food marketplace that is
demanding labeling and remains extremely skeptical of genetically
engineered food.'
This Comment will first describe the types of recombinant DNA
techniques being used to modify foods, and the differences between
5. See id.
6. See EU's Fischler Says All GMO Food Must be Labeled, REUTERs NEWs
SERV., Sept. 19, 1997.
7. See Burros, supra note 4.
8. See Statement of Policy: Foods Derived From New Plant Varieties, 57 Fed.
Reg. 22,984 (1992).
9. See, e.g., Thomas J. Hoban, Anticipating Public Reaction to the Use of Genetic
Engineering in Infant Nutrition, 63 AM. J. CLINICAL NUTRrnON 657S (1996).
10. See, e.g., Distrust in Genetically Altered Foods, 383 NATURE 559 (1996).
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recombinant DNA and traditional breeding techniques. Included is a
discussion of the advantages driving the rapid pace of development of
genetically engineered foods, as well as the dangers to both the
environment and public health posed by these foods. Second, this
Comment will address the public perception of the threat presented by
genetically engineered foods. This includes a discussion concerning the
ability to improve consumer awareness and acceptance of such foods
through product labeling, together with other appropriate educational
initiatives. Third, this Comment will highlight the authority granted to
the FDA regarding labeling of genetically engineered foods, and the
inadequacy of the current FDA position on labeling in light of the
legitimate health concerns being voiced by scientists and consumer
advocacy groups. Fourth, this Comment will address the ability of
individual states to require labeling of genetically engineered foods in
the face of federal inaction. This requires a discussion of the potential
for numerous state standards to disrupt commerce, whether states may
require labeling without running afoul of the Supremacy Clause of the
U.S. Constitution or First Amendment protections of commercial
speech, and what interests states may take into account when
determining what is a "substantial interest". Fifth, this Comment will
address the international movement towards labeling of all genetically
engineered foods. Included is a discussion of the demands made by non-
U.S. consumers for comprehensive labeling of genetically engineered
foods, the efforts by various governments to satisfy these demands, and
the potential for a proliferation of standards to disrupt the international
trade in food. In this context, this Comment stresses the need for the
United States to provide leadership in setting a global labeling standard
under the auspices of the Codex Alimentarius Commission." Finally,
potential federal regulations will be proposed under the authority of the
Federal Food, Drug and Cosmetic Act (FDCA)'2 by addressing a series
of questions posed by the FDA itself. These questions include 1) how
should genetic engineering be defined; 2) what characteristics of foods
derived from genetic engineering distinguish such foods; 3) is labeling
appropriate for both fresh produce and processed foods; 4) is there a
basis in science to differentiate between genetic engineering techniques
and traditional breeding techniques; and 5) is it feasible to provide such
11. See JOINT FAO/WHO CODEX ALimENTARIUS COMMIssION, Codex
Alimentarius Commission: Procedural Manual (8th ed. 1993).
12. 21 U.S.C. §§ 301-395. (1994 & Supp. II 1997).
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labeling?
II. GENETIC ENGINEERING OF FOOD-POTENTIAL BENEFITS AND RISKS
Prior to 1900, agricultural breeding techniques had remained largely
unchanged for approximately ten thousand years.13  At that time, the
rediscovery of work by Gregor Mendel on the heritability of genetic
traits'4 began to provide geneticists with the necessary tools to
selectively breed plants and animals. So while early agriculture was
content with domestication of wheat, for example, the advent of modem
genetics made it possible to direct the evolution of wheat, with the goal
of producing a desirable new "hybrid" variety. The net results of nearly
one hundred years of what are now considered traditional breeding
practices" are plants and animals displaying enhanced yields, disease
resistance, and nutrition. Consequently, few modem agricultural
products can escape being labeled "genetically modified." Hybrids
created by traditional techniques are, however, typically limited to
closely related species.'6 Transferring genetic information between cow
and pig, fish and tomato, or soybean and Brazil nut, is impossible using
traditional breeding techniques.
This limitation has been largely overcome in the last few years
through the application of recombinant DNA technologies. These
technologies, commonly referred to as "genetic engineering,"" allow the
introduction of specific DNA sequences from any source into an
agricultural product. While traditional breeding techniques allow the
directed evolution of a plant or animal, the exchange of genetic material
between parent strains that result in a new hybrid is relatively crude and
largely uncontrollable. By comparison, genetic engineering techniques
allow the insertion of a desired trait into a plant or animal with pinpoint
13. See Kenneth J. Frey, An Overview of Crop Improvement: Chairman's
Introduction, in GENETIC ENGINEERING OF PLANTS: AN AGRICULTURAL PERSPECTIVE, at 3
(T. Kosuge et al., eds., 1983).
14. See Gregor Mendel, Versuche tiber Pflanzen Hybriden (Experiments in Plant
Hybridization), 4 VERHANDLJNGEN DES NATURFORSCHEDEN VEREINES IN BRUNN 3
(1866). Mendel originated the study of genetics with this seminal work. The importance
of this work went unrecognized until the turn of the century.
15. These traditional techniques include hybridization within a species,
mutagenesis by physical or chemical means, tissue culture techniques, and wide crosses.
See Statement of Policy: Foods Derived From New Plant Varieties, 57 Fed. Reg. 22,984-
86 (1992).
16. An example of the limits of traditional techniques would be transferring
genetic material between a modem crop plant and a related wild species. See id.
17. Genetic engineering refers to any technique capable of producing a transgenic
plant or animal. See generally ANIMALS WrrI NOVEL GENES (Norman MacLean ed.,
Cambridge Univ. Press 1994). See also GENETIC IMPROVEMENTS OF AGRICULTURALLY
IMPORTANT CROPS (Robert T. Fraley et al. eds., Cold Spring Harbor Lab. 1988).
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accuracy. This trait could range from production of a novel protein
introduced from a completely unrelated genus,'" to enhanced production
of a normal constituent protein,' or to elimination of an undesirable
normal constituent protein.' The goal of agricultural genetic
engineering remains the same as in traditional breeding-improved
agricultural products. But recombinant DNA technologies greatly
expand the range of possible improvements. Genes may now be moved
without regard to species barriers. Pigs that have better yields because
they express cow genes" or soybeans that have improved nutritional
value due to the addition of a Brazil nut proteinn are now a reality.
The benefits to the farmer and to the consumer of this powerful
technology are potentially enormous and should not be
underemphasized.2' Transgenic plants containing natural insecticides
may reduce the need for chemical pest control, benefiting the
environment (which is now exposed to a barrage of harmful chemicals
used in modem farming), farmers (who must now deal with an array of
potentially harmful pesticides), and consumers (who ingest foods
contaminated with pesticide residues). Transgenic plants with increased
resistance to herbicides may make it possible to use less toxic herbicides
and increase crop yields.A Transgenic fruit that delays ripening may
18. For example, bacterial toxins may now be introduced into plants, creating a
transgenic plant with enhanced insect resistance. See, e.g., Nicolai Strizhov et al., A
Synthetic cryIC Gene, Encoding a Bacillus thuringiensis 5-Endotoxin, Confers
Spodoptera Resistance in Alfalfa and Tobacco, 93 PRoc. NAT'L. ACAD. SCI. 15,012
(1996).
19. A typical example is the overproduction of desirable proteins in food
fermenting bacteria used by the dairy industry. See, e.g., G.G.A. Pascalle et al.,
Controlled Gene Expression Systems for Lactococcus lactis with the Food-Grade
Inducer Nisin, 62 APPLIED & ENVTL. MICROBIOLOGY 3, 662 (1996).
20. Calgene's Flavr Savr tomato is an example of an agricultural product produced
by this strategy. The tomato protein responsible for fruit softening during ripening was
reduced in quantity through the incorporation of an "antisense" gene into the transgenic
tomato. The product of the antisense gene blocks the tomato's "sense" gene product by
binding to it. See Peter R. Day, Genetic Modification of Plants: Significant Issues and
Hurdles to Success, 63 AM. J. CLNICAL NUTRrITON 65 1S, 653S (1996).
21. See New Type Pigs in the Future: Genetic Engineering Could Develop Porkers
with Special Milk Traits, ROCKY MTN. NEws, Apr. 14, 1996, at 32A.
22. See Julie A. Nordlee et al., Identification of a Brazil-Nut Allergen in
Transgenic Soybeans, 334 NEv ENG. J. MED. 688 (1996).
23. See Day, supra note 20. See also Hoban, supra note 9.
24. See, e.g., George Monbiot, Watch These Beans, THE GUARDAN (London),
Sept. 17, 1997, at 17 (outlining the development of "Roundup Ready" crops by the
chemical firm Monsanto). Roundup is the trade name for the pesticide glyphosate.
Roundup is a non-specific herbicide used to eliminate any plant growth on treated land,
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provide improved shipping characteristics and better flavor. Transgenic
soybeans and oil seeds with improved nutritional value may improve the
diets of both humans and farm animals. Milk from transgenic cows may
be made to more closely resemble human milk, resulting in positive
effects on infant nutrition. Given such potential, genetic engineering of
food will continue to be a fact of life for the consumer.25
Along with these potential gains, however, come a number of
potential risks to both humans and the environment. While crops may
be engineered to contain natural insecticides, insects can adapt,
becoming resistant much more quickly than expected. 6 The intense
selective pressure on insect populations from large-scale plantings of
such crops may destroy the effectiveness of natural insecticides relied
upon by organic farmers and those not planting transgenic crops. 7
Farmers are attempting to mitigate this threat through resistance
management plans, but the effectiveness of these plans remains
uncertain.' The planting of crops containing herbicide resistance genes
may, ironically, result in increased herbicide use, as farmers would be
free to use herbicides to control weeds without fear of harming the crop
plants themselves. 29  Further, the crop plants may transfer these
resistance genes to wild plants, potentially creating herbicide-resistant
killing crop plants and weeds alike. If crops are made resistant to Roundup (i.e.
"Roundup Ready"), the farmer is free to employ Roundup to eliminate all the weeds that
might compete with the crop for nutrients. The advantages to Roundup are its short
lifetime in the environment and its low toxicity to animals. Day, supra note 20, at 652S.
Interestingly, the bacterium that provided the gene for resistance to Roundup was found
living in the effluent from a Monsanto plant which produced the herbicide. See Genetic
Engineering: The Year of the Triffids, ECONOMIST, Apr. 26, 1997, at 80. This serves to
emphasize that when man pushes nature, nature finds ways to adapt.
25. Sales of genetically engineered seeds are expected to reach $20 billion within a
decade. See Nancy Millman, Deal Plants Seeds For Future Farmers; DuPont-Pioneer
Joint Venture to Boost Genetic Engineering, Cm. TRIB., Aug. 8, 1997, at B1.
26. See Bruce E. Tabashnik et al., One Gene in Diamondback Moth Confers
Resistance to Four Bacillus Thuringiensis Toxins, 94 PROC. NAT'L. ACAD. Sci. 1,640
(1997).
27. See Meredith Wadman, Dispute Over Insect Resistance to Crops, 388 NATURE
817 (1997). See also EPA Violated Law in Approving Bt Crops-Greenpeace, REUTERS
Nmvs SERV., Sept. 16, 1997 (discussing Greenpeace's initial steps toward bringing suit
against the U.S. Environmental Protection Agency over approval of plants engineered to
produce a toxin from Bacillus thuringiensis); Bruce E. Tabashnik, Seeking the Root of
Insecticide Resistance to Transgenic Plants, 94 PRoc. NAT'L. ACAD. Sci. 3488 (1997)
(showing that, without measures to delay the selection of resistant pests, large scale
planting of transgenic crops containing Bt toxin will render this currently effective pest
control method ineffective within a few years).
28. See Tabashnik, supra note 27, at 3489 (discussing the limitations of one
popular resistance management tactic, the use of refuges of non-transgenic crops to
decrease the intensity of selection pressures on the local insect population).
29. See, e.g., Monbiot, supra note 24.
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weeds that are a threat to the environment.0
Of course, these ecological and environmental risks do not impact the
FDA and its position on food labeling.' Rather, FDA scratiny is limited
to potential dangers arising from consuming genetically engineered
foods. It is in this light that the FDA asks whether genetic engineering
"would result in foods which, as a class, exhibit attributes different from
foods derived by other methods of plant breeding?"32 A more direct
concern to the FDA, then, is the possible health risk presented by foods
containing unknown or unexpected proteins. Transgenic soybeans may
be made more nutritious by the addition of Brazil nut protein, but to an
individual allergic to Brazil nuts, consuming a food containing this
protein may present a life-threatening situation.3 Even trace amounts of
such an allergen can trigger a potentially fatal reaction.34 Further,
antibiotic resistance proteins used for selection of transgenic plants3
30. See Thomas R. Mikkelsen et al., The Risk of Crop Transgene Spread, 380
NATuRE 31 (1996).
31. Individual states and other countries are not so limited as to risks they may
take into account. Ecological and environmental concerns may certainly impact these
other soverigns in their own decisions to require labeling of genetically engineered
foods. See discussion infra parts IV and V.
32. See Food Labeling; Foods Derived from New Plant Varieties, 58 Fed. Reg.
25,837,25,839 (1993).
33. See Nordlee, supra note 22. Food allergies are on the rise in recent years,
occurring in one to two percent of the general population and in as high as eight percent
of children. Typical reactions in food allergies are asthma, rhinitis, dermatitis, urticaria,
and anaphylaxis. The only effective therapy for food allergies is avoidance of the
threatening food. See Food Allergy, E. R. Pearl, 1 LIPPiNcoTT's PRIMARY CARE
PRACTICE 154 (1997).
34. See, e.g., Theresa Tamkins, More Cases of Food Allergy Being Diagnosed,
REuTERS NEws SERV., Sept. 19, 1997 (children's deaths from exposure to peanut
allergens in foods made with "clean" utensils that had previously only touched peanut
butter); Lorraine Shank, The Truth About Food Allergies; Sufferers Always Face Danger
of Hidden, Related Ingredients, THE PLAIN DEALER, Oct. 16, 1996, at 1E (child's near
fatal allergic reaction to walnut allergens, resulting from a mother's touch on the face
with her "clean" hands that had earlier touched walnuts); Jim Atkinson, Food Fright,
TExAs MONTHLY, Aug. 1997, at 64 (child's near fatal allergic reaction to peanut
allergens, resulting from a kiss good-night from her brother who had eaten peanut butter
earlier).
35. See Robert A. Bohrer, Food Products Affected by Biotechnology, 55 U. Prrr.
L. REv. 653, 673-74 (1994). Transformation (i.e., the transfer of a gene from a donor
organism to a host organism) of plants is not 100% efficient. The transformed plants
must be selected from those that are not expressing the new gene. Resistance genes, to
antibiotics or herbicides, are typically inserted as markers for the gene of interest. Those
plants that have become transformed and are expressing the desired gene will also
express the resistance protein, and hence survive treatment with the selected antibiotic or
herbicide. This selection method was used in Calgene's Flavr Savr tomato. See id. at
1221
have the potential to render commonly used antibiotics less effective by
inhibiting their uptake, 6 or by conferring antibiotic resistance to bacteria
in the gastrointestinal tract." The consumer lacks the information
necessary to determine their exposure to, and hence risk from, antibiotic
resistance proteins in the diet. This limitation applies equally to the
physician who is prescribing an antibiotic in order to fight infection.
Finally, even though a protein added by genetic engineering might exist
at safe levels in a single food, these same proteins might become a
danger as more and more foods in the typical diet become genetically
engineered and exposure levels become addictive.
DI. CONSUMER PERCEPTIONS OF THE THREAT POSED BY
GENETICALLY ENGINEERED FOODS
The ultimate success of genetically engineered foods in the
marketplace will require acknowledgment of the presence of such foods
by the producer and acceptance of that fact by the consumer. That
acceptance will not come unless consumers gain confidence that such
food is safe to grow and to eat. It has been noted that the American
public has a growing skepticism of science generally, and
biotechnology, in particular.38 Polls consistently find strong public
opposition to genetic engineering,39 though education can significantly
reduce this opposition.40 Current public awareness and understanding of
670.
36. See id. at 673-74.
37. See Distrust in Genetically Altered Foods, supra note 10. The ability of
pathogenic bacteria to develop resistance to antibiotics is a major threat to our ability to
fight common diseases. The presence of multiple-antibiotic-resistant bacteria in the
human food chain has already been demonstrated. See Vincent Perreten et al., Antibiotic
Resistance Spread in Food, 389 NATURE 801 (1997). In the laboratory setting, bacteria
can become transformed by DNA (antibiotic resistance genes from genetically
engineered foods for example). Little is known about the ability of bacteria to become
transformed within the human gastrointestinal tract, though scientists consider the
prospect likely. See Julian Davies, Inactivation of Antibiotics and the Dissemination of
Resistance Genes, 264 SCIENCE 375, 380 (1994). It is important to recognize that the
transfer of antibiotic resistance genes to bacteria need not occur in the human
gastrointestinal tract. As animal feed also becomes increasingly genetically engineered,
transformation could occur just as easily in the gastrointestinal tract of food animals,
such as cattle. See Perreten, supra, at 802. Bacterial contamination of consumed meat
would then allow these cattle bacteria to deliver the acquired antibiotic resistance gene to
bacteria within the human gastrointestinal tract. See A.P. Johnson et al., Gentamicin
Resistance in Clinical Isolates of Escherichia coli Encoded by Genes of Veterinary
Origin, 40 J. MED. MICROBIOLOGY 221 (1994).
38. See Edward S. Golub, Public Perception of Biotechnology: Genetically
Enhanced Food for Thought, 15 NATURE BIOTECHNOLOGY 112 (1997).
39. See Surveys and Their Findings; New Issues. Genetic Engineering, PUB.
PERSPECTIVE, June-July 1997, at 42.
40. See Hoban, supra note 9, at 658S-59S.
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agricultural biotechnology is dangerously deficient,41 leaving consumers
without the tools necessary to make sound informed decisions about the
risks and benefits of genetically engineered food.
It is true that food choice is a complicated matter. It is further true
that simply providing information is not sufficient to change consumer
behavior.42 But it has long been the goal of Congress and the FDA for
food labeling to be used for "communication of essential information to
enable consumers to choose foods more wisely. 43 Indeed, food labels
represent a significant source of information for most Americans 4
Labeling of genetically engineered foods is required to alert consumers
to the presence of such foods in their diet. Labeling of genetically
engineered foods also represents a necessary first step in the effort to
educate consumers on the risks and benefits of such foods. This does
not mean that a larger educational effort beyond labeling should not be
undertaken. Recent research regarding how to best present food and
nutrition information to consumers45 can provide guidance for this
educational effort. If the food industry wishes to profit from genetically
engineered foods, it is incumbent upon them to lead this educational
41. See id. at 660S.
42. See Helena W. Vaandrager & Maria A. Koelen, Consumer Involvement in
Nutritional Issues: The Role of Information, 65 AM. J. CLINICAL NUTRIrrON 1980S
(1997).
43. Frederick H. Degnan, The Food Label and the Right to Know, 52 FOOD DRUG
L.J. 49,54 (1997).
44. See, e.g., Food Labels Impact Shopping Choices, REuTERS NEWS SERV., Sept.
5, 1997 (discussing the results of the latest American Dietetics Association poll on the
impact of food labels on shopping choice, in which two-thirds of Americans say they
make changes in food purchases based upon labels). Recognizing the importance of
food labeling in the context of food allergies, a number of commentators have stressed
the need for accurate content labeling of foods. See, e.g., Hugh A. Sampson, Managing
Peanut Allergy: Demands Aggressive Intervention in Preventional and Treatment, 312
BRr. MED. J. 1050 (1996) ("Finally, the medical community should put pressure on
governmental agencies responsible for product labeling .... "); Shank, supra note 34, at
El ("[Individuals with food allergies] need to be avid label readers."); J.J. Hanley,
Allergy Attack; Minimizing the Risk of Food Allergies, 58 FOOD PROCESSING 79 (1997)
("[O]ne of the most important things a company can do to reduce the number of food
allergy incidences is to communicate with the consumer through its package label.").
45. See Food Labels Impact Shopping Choices, supra note 44 (discussing
strategies for public health professionals to provide food and nutrition education). See
also Communicating Emerging Scientific Information, 54 NutrrION REV. 153 (1996)
(reviewing the need for effective information transfer from scientists to the public);
Hoban, supra note 9 (applying social science research techniques to education of the
public about bioengineered foods); Lester H. Myers, Food Consumption Data Needs for
Food and Agricultural Policy, 124 J. NUTRION 1853S (1994) (outlining data collection
strategies for public policy purposes).
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effort.
The failure to inform consumers of the presence of genetically
engineered foods in their diets through proper labeling, together with the
failure of the food industry to educate consumers about the risks and
benefits involved, presents a potentially volatile situation. The average
consumer is inept at measuring and understanding relative risks. As an
example, the risks of air travel are often believed to be far greater than
the risks of automobile travel, when, in fact, that is quite to the contrary.
To an insufficiently educated public, the sudden, frightening disclosure
of even small risks can result in disastrous losses of both money and
consumer confidence for food producers. One example of such a
disastrous outcome in the context of a perceived threat to food safety
was seen in response to a 1989 story on the CBS television news
magazine "60 Minutes" concerning residues of the chemical Alar on
apples. Ala was used by growers to boost crop yields and promote
fruit color development. Alar is also classified as a probable human
carcinogen.4" Sales of apples plummeted as frightened consumers and
food processors stopped purchasing apples, even though only four
percent of the nation's apple crop was being treated with Alar, and Alar
residues in fresh market apples were far below Environmental Protection
Agency (EPA) standards.49 As a result of consumers' loss of confidence
in the safety of apples, "apple growers and others dependent upon apple
production lost millions of dollars. Many of the growers lost their
homes and livelihoods."50 Alar was subsequently removed from use on
food in November 1989."' Given the unease with which consumers view
agricultural biotechnology, one can reasonably assume the response to a
story concerning the safety of genetically engineered foods would be at
least equal to that seen concerning Alar. Only "[o]pen communication
and prudent education will help to establish confidence in bio-
engineered products. 52 For the typical consumer, communication and
education begins with labeling.
46. See Auvil v. CBS "60 Minutes", 67 F.3d 816 (1995) (discussing the "60
Minutes" story "A is for Apple", aired Feb. 26, 1989, and its aftermath).
47. Alar is the brand name for daminozide (chemical name butanedioic acid mono
(2,2-dimethylhydrazide)), produced by the Uniroyal Chemical Company.
48. See Tolerances and Exemptions from Tolerances for Pesticide Chemicals in or
on Agricultural Commodities, 40 C.F.R. § 180 (1997). See also Pesticide Tolerance for
Daminozide, 52 Fed. Reg. 28,256 (1987).
49. See Florence Fabricant, Food Notes, N.Y. Tms, Jan. 7, 1987, at C7; Apple
Industry Takes Action on Alar, BusnqEss WIRE, Feb. 9, 1989.
50. Auvil, 67 F.3d at 819.
51. See Daminozide: Termination of Special Review of Food Uses, 54 Fed. Reg.
47,492 (1989).
52. Kurt Danner, Acceptability of Bio-Engineered Vaccines, 20 COMP.
IMMUNOLOGY, MICROBIOLOGY & INFECTIOus DIsEAsEs 3, 11 (1997).
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IV. CURRENT FDA REGULATIONS FOR LABELING GENETICALLY
ENGINEERED FOODS
Regulatory authority for food labeling is granted to the FDA by the
Federal Food, Drug and Cosmetic Act. 3 Under an FDA regulatory
scheme first articulated in 1992,-4 foods created through the use of
recombinant DNA technologies are treated as though they are not
fundamentally different from foods created through traditional breeding
techniques. Producers are required to describe a food product by a
common name, or otherwise use appropriately descriptive terms.55 This
applies equally to all foods, regardless of whether they originate from
either recombinant DNA or traditional breeding techniques. All facts
that are material with respect to customary use of the food, including
issues of food safety and usage, must be disclosed.56
The FDA's regulatory approach does not consider the fact that
recombinant DNA technologies were used to produce a food to be a
material fact per se,57 just as the traditional breeding techniques used are
not considered material facts. Nor is the addition of DNA itself viewed
as use of a food additive. FDA policy notes that typically, DNA is not
infused directly into food. Rather, the source DNA is first copied in a
laboratory, then inserted into the recipient agricultural product such that
the DNA becomes an integral part of the recipient's genetic information.
This new DNA is then indistinguishable from all other DNA in the
recipient." As DNA is a normal constituent of any living thing, DNA as
a component of food is presumed to be "generally regarded as safe"
("GRAS").
59
Of course, the utility of DNA in genetic engineering does not lie in the
DNA itself, but instead in the expression of that DNA once it is inserted
into the recipient plant or animal. Rather than the addition of DNA then,
it is the products of DNA expression that come under FDA scrutiny.
53. See 21 U.S.C § 343 (1994).
54. See Statement of Policy: Foods Derived From New Plant Varieties, 57 Fed.
Reg. 22,984 (1992).
55. See 21 U.S.C. § 343(i).
56. See 21 U.S.C. § 321(n) (1994).
57. See Statement of Policy: Foods Derived From New Plant Varieties, 57 Fed.
Reg. at 22,984, 22,991 (1992).
58. See Food Labeling; Foods Derived from New Plant Varieties, 58 Fed. Reg.
25,837, 25,839 (1993).
59. Statement of Policy: Foods Derived From New Plant Varieties, 57 Fed. Reg.
22,984, 22,990 (1992).
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Labeling is required to alert the consumer only if the genetically
engineered food differs from the original food to such an extent that
either the common name no longer applies, or a safety issue is
apparent.6 Addition of a foreign gene, without anything more, would
not be sufficient to trigger the labeling requirement. Pointedly, the FDA
states "a tomato does not become 'fish-like' following the addition of a
copy of a fish gene.",61 Insufficient knowledge of the introduced
protein's potential to cause allergic reactions in a susceptible population,
however, would trigger a labeling requirement,62 as would introduction
of a protein with known allergic potential.63
A significant limitation to the FDA's regulatory approach lies in its
determination of the allergenicity or toxicity of genetically engineered
foods. While it is certainly true that a tomato containing a fish gene
does not begin to swim around, it certainly does become in some sense
fish-like. This is particularly true for the individual who is allergic to
the product of that fish gene. Determining if a population exists that is
allergic to a novel food will largely be left to prior experience with the
added protein.64 Thus, a genetically engineered soybean with a Brazil
nut protein will be judged safe (or unsafe) based on experience with
consumption of Brazil nuts. Food producers are permitted by the FDA
to make their own determination that the added protein is GRAS.S So,
with the exception of the few known food allergens and toxins, food
producers are allowed "to determine independently the safety of the
resulting food" without any automatic "[a]gency review of a
manufacturer's food safety data." The FDA's approach will likely be
successful for the majority of people and the majority of foods. No
evidence exists that proteins added by recombinant DNA techniques will
be more allergenic than normal proteins. 67 Nor is there evidence such
proteins will be less allergenic, however. There are currently no
methods to determine the allergenic potential of recombinant proteins
beyond the very few that are previously known to be allergens.6
60. See id. at 22,991.
61. Food Labeling; Foods Derived from New Plant Varieties, 58 Fed. Reg. 25,837,
25,839 (1993).
62. See Statement of Policy: Foods Derived From New Plant Varieties, 57 Fed.
Reg. 22,984, 22,991 (1992).
63. See Food Labeling; Foods Derived from New Plant Varieties, 58 Fed. Reg.
25,837, 25,840 (1993).
64. See Statement of Policy: Foods Derived From New Plant Varieties, 57 Fed.
Reg. 22,984, 22,987 (1992).
65. See Bohrer, supra note 35, at 662.
66. Id.
67. See Samuel B. Lehrer et al., Why are Some Proteins Allergenic? Implications
for Biotechnology, 36 CRrmcAL REv. FOOD SCL & NUrmrTION 553 (1996).
68. See id. at560-61.
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Predicting whether recombinant proteins not known to be allergens are
"expressed in such a fashion that they have substantial allergenic
activity"" is problematic, and the results of exposure to such proteins in
a susceptible population can be quite severe. "Avoidance may be the
only means of preventing the adverse reaction."'7 It is likely, in the
absence of required labeling, educational efforts, or effective testing,
adverse reactions to genetically engineered food will occur, resulting in
the potential to erode public confidence in the safety of genetically
engineered agricultural products.
V. THE POTENTIAL FOR INDIVIDUAL STATE REGULATION OF
LABELING GENETICALLY ENGINEERED FOODS
The regulatory vacuum created by the FDA's position on labeling
genetically engineered foods should cause enough concern that each of
the fifty states might try to fill that vacuum by individually mandating
labeling. It is clear, however, that a proliferation of up to fifty differing
labeling statutes would cause disruption in the commercial market. A
recent settlement between the state, of Illinois and several dairy product
producers who wished to label their products "rBGH-free ' 2 emphasizes
that, with a need to maintain consistent packaging and minimize costs, it
is not feasible for national companies to label products differently for
individual markets.' Nonetheless, in an effort to protect consumers,
individual states will likely step into the breach created by the FDA's
failure to propose a national labeling standard.74 These efforts may vary
from voluntary labeling initiatives aimed at satisfying consumer
69. Id. at 560.
70. See David Kitts et al., Adverse Reactions to Food Constituents: Allergy,
Intolerance, and Autoimmunity, 75 CAN. J. PHYSIOLOGY & PHARMACOLOGY 241 (1997).
71. Id. at 251.
72. Bovine growth hormone (BGH), or bovine somatotropin (BST), is a hormone
produced normally in the pituitary gland of cattle. Produced through recombinant DNA
technology, rBGH can be injected into dairy cattle, with a resulting increase in milk
production of as much as 20%. rBST was approved in the U.S. in 1993. Consumer
advocates continue to question the effect on humans of residual rBST in dairy products
and meat from treated cattle. See Bohrer, supra note 35, at 674-78; see also Beth
Berselli, Settlement Reached in Hormone Labeling Case; Ben and Jerry's, States Agree
Food Makers Can Indicate Absence of Added Product, WASH. POST, Aug. 15, 1997, at
A22.
73. See Berselli, supra note 72.
74. A bill requiring labeling of genetically engineered foods has been proposed in
at least one state. See H.B. 790, 1l8th Leg., lstReg. Sess. (Me. 1997).
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curiosity to allowing for "free from genetic engineering" labeling,75 or to
comprehensive initiatives along the lines of California's Proposition
65.76 Clearly, as pointed out by a Maine commission on biotechnology,
a national standard for labeling genetically engineered foods established
by the FDA would be preferable to action at the state level."
In asking whether individual states may mandate labeling of
genetically engineered foods, one must first address the possibility that
the FDCA effectively preempts any state regulation of the food label.79
Because there is no specific preemption language in the FDCA itself,9
the notion of preemption of state legislation is implied, under the
Supremacy Clause of the U.S. Constitution.'° Interpretation of the
Supremacy Clause by the U.S. Supreme Court indicates that compliance
with federal standards does not immunize against compliance with a
more stringent state standard."' Rather, preemption will only be implied
when the state regulation stands as an obstacle to the objectives of
Congress. Specifically, there must be "such actual conflict between the
two schemes of regulation that both cannot stand in the same area, [or]
evidence of a congressional design to preempt the field." 2
It is against this standard, then, that state legislation regulating food
labels has been measured. Courts have found state legislation regarding
food labels to not be automatically preempted under the FDCA (or under
its predecessor, the Pure Food and Drugs Acte3).' Instead, such
legislation is only preempted when compliance with both the state and
75. International Dairy Foods Ass'n. v. Amestoy, 92 F.3d 67,74 (2d Cir. 1996).
76. See Safe Drinking Water and Toxic Enforcement Act of 1986, CAL. HEALTH &
SAFETY CODE §§ 25249.5-.13 (West Supp. 1998) (mandating widespread warning labels
for any chemical known to the state of California to cause cancer or reproductive harm).
77. See Labeling; Mandatory Premarket Review Recommended by Maine
Commission on Biotechnology, 38 FOOD CHEMICAL NEWS 1 (1996).
78. For a thorough review of this issue, see Diane M. Allen, Annotation, Federal
Pre-Emption of State Food Labeling Legislation or Regulation, 79 A.L.R. FED. 181
(1996).
79. See id. at 182. The mere fact that federal regulation exists in a given field does
not indicate that federal law occupies the field to the exclusion of state regulatory power.
See id.
80. See U.S. CONST. art. VI, cl. 2.
This Constitution, and the Laws of the United States which shall be made in
Pursuance thereof; and all Treaties made, or which shall be made, under the
Authority of the United States, shall be the supreme Law of the Land; and the
Judges in every State shall be bound thereby, any Thing in the Constitution or
Laws of any State to the Contrary notwithstanding.
Id.
81. See Florida Lime & Avocado Growers, Inc. v. Paul, 373 U.S. 132, 141 (1963).
82. Id.
83. See 34 Stat. 768 (1906).
84. See Grocery Mfrs. of America, Inc. v. Gerace, 755 F.2d 993 (1985).
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federal statutes is impossible.'1 For example, state regulations dealing
with labeling of egg weights, milk fat content in ice cream7 or
requiring more detailed ingredient lists88 were held not preempted.
Conversely, regulations which provided a definition of "imitation," 9 or
which prohibited the use of the word "butter,"'8 in direct conflict with
the FDCA, were held preempted. Accordingly, while any state statute
regulating labeling of genetically engineered food must be drafted
carefully so as not to actually conflict with the FDCA, such statutes are
not preempted under the Supremacy Clause per se. The fact that a state
standard is more stringent concerning labeling of genetically engineered
foods than the FDA standard is not sufficient to create a direct conflict
between state and federal regulations.
In addition to the potential to run afoul of the Supremacy Clause of the
U.S. Constitution, a recent U.S. Court of Appeals decision suggests that
state labeling mandates may also run afoul of First Amendment
protections of commercial speech. A Vermont statute,9' which required
the labeling of dairy products produced from cattle treated with
recombinant bovine somatotropin (rBST), was found to be an
unacceptable restriction on commercial speech. 3  Noting that the
Vermont statute was not aimed at suppressing speech, but rather at
compelling the disclosure of methods used by dairy producers in
production of dairy products, the court recognized that First Amendment
protections include both the right to speak, as well as the right to refrain
from speaking. 4 Further, the court found, although purely commercial
speech is accorded a lesser protection under the First Amendment than
the strict scrutiny standard accorded to other constitutionally protected
speech, the Vermont statute failed to meet even the less stringent
85. This statement is not limited to food labeling under FDCA, but also extends to
state legislation impacting the Federal Meat Inspection Act, 21 U.S.C. §§ 601-695
(1994), and the Poultry Products Inspection Act, 21 U.S.C. §§ 451-470 (1994). See also
Allen, supra note 78, for a detailed discussion.
86. See L & L Started Pullets, Inc. v. Gourdine, 592 F. Supp. 367 (1984).
87. See Borden Co. v. Liddy, 200 F. Supp. 221 (S.D. Iowa 1961).
88. See Savage v Scovell, 171 F. 566 (E.D. Ky. 1908).
89. See Gerace, 755 F. 2d at 993.
90. See Lever Bros. v. Maurer, 712 F. Supp. 645 (S.D. Ohio 1989).
91. VT. STAT. ANN. tit. 6, § 2754 (1996).
92. See supra note 72, for an explanation of rBST.
93. International Dairy Foods Ass'n v. Amestoy, 92 F.3d 67, 67 (2d Cir. 1996).
94. See id. at 71.
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constitutional protections for commercial speech.95
While it is certainly true that state governments may restrict, or
compel, commercial speech in the public interest, the Supreme Court has
set out a four-part test to determine whether such regulations pass
constitutional muster.96 In the case of a food labeling law compelling
speech, the test is: (1) whether the compelled speech concerns lawful
activity and is not misleading; (2) whether the government interest is
substantial; (3) whether the labeling law serves that interest; and (4)
whether the law is no more extensive than necessary. 7 In the case of the
Vermont labeling statute, the court held that Vermont failed to identify a
substantial interest. Vermont attempted to justify its labeling statute
based solely on "the existence of consumer concern,"98 an interest the
court "reluctantly" found inadequate. It is worth noting the dissent
believed Vermont had demonstrated a substantial interest based upon
concerns for bovine health, for effects on dairy industry well-being, and
for safety of recombinant gene technology, in general, and rBST, in
particular.' The majority did not disagree that these concerns present a
substantial interest. Rather, the majority found Vermont did not base its
labeling statute upon these concerns.'
It seems clear from the appeals court's discussion in International
Dairy Foods Ass'n. v. Amestoy' 2 that a state could certainly draft a
statute mandating labeling of genetically engineered foods that
successfully passes constitutional muster with regard to First
Amendment issues. Note that the required substantial government
interest is not limited to issues of food safety alone. Just as Vermont
may consider the effect on bovine health, philosophic objections to
biotechnology and the economic effect on the dairy industry when
drafting a labeling law regarding use of rBST, °3 states are free to
consider philosophic opposition to the use of genetic engineering in food
crops and animals, possible environmental threats posed by genetic
engineering" and food safety when determining if a substantial interest
to require labeling exists. Crafting a labeling statute which is not
95. See id. at 72.
96. See Central Hudson Gas & Elec. Corp. v. Public Serv. Conim'r, 447 U.S. 557,
566 (1980).
97. See id.
98. International Dairy Foods Ass'n. v. Amestoy, 898 F. Supp. 246, 249 (D. Vt.
1995).
99. See International Dairy Foods Ass'n. v. Amestoy, 92 F.3d at 73.
100. See id. at 75.
101. See id. at 73 n.1.
102. 92 F.3d 67 (2d Cir. 1996).
103. See id. at 78.
104. See supra part II.
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misleading, which addresses this substantial interest and which does so
with the minimum restriction on commercial speech, is certainly within
the ability of every state legislature. It is likely that such state-mandated
labeling of genetically engineered foods will be challenged in the courts.
Further, these court challenges will occur on a state-by-state basis. A
single federal standard would serve to both preempt state efforts at
labeling, and to settle the issue in a timely fashion with a minimum
amount of litigation.
VI. LABELING GENETICALLY ENGINEERED FOODS FOR THE
WORLD MARKET
While U.S. consumers can be characterized as wary of accepting
genetically engineered food, consumers outside the United States can
best be characterized as deeply distrustful of any use of recombinant
DNA technology to modify foods. In Britain, retailers are facing
demands from consumers to trace the origins of food products in the
wake of the BSE0 5 crisis. As a result, members of the British Retail
Consortium recently began a boycott of American soy-based products
because of the failure to label lots containing genetically engineered
soybeans.' 6 Chefs in Britain have demanded labeling laws that would
enable them to keep genetically engineered foods off their menus." In
France, the government has threatened to ban imports of genetically
engineered corn from the United States due to a disagreement with the
European Parliament over labeling rules." In Switzerland, opponents of
genetic engineering have introduced an initiative to Parliament to forbid
many types of genetic engineering and restrict most others. Much of this
distrust has been described as stemming from the high environmental
105. Bovine Spongioform Encephalopathy, or "mad cow" disease, caused a panic
amongst the beef eating public in Britain in 1996, and resulted in the collapse of the
British beef industry. The consumption of infected beef appears to be the cause of a
number of cases of fatal human disease (known as Creutzfeld-Jakob disease). The panic
stems from three sources. These are the 1) unusual nature of the infectious particle,
known as a "prion", 2) the nature of the disease, a degenerative and ultimately fatal
damage to the brain, and 3) a loss of confidence in government ability to protect
consumers. See Ehsan Masood, 'Mad Cow' Scare Threatens Political Link Between
Food and Agriculture, 380 NATURE 273 (1996).
106. See Supermarkets Ban US Soy Beans in Own-label Products, MARKETING
WK., Aug. 16, 1996, at 10.
107. See Roger Williams, Chefs Join Protest Over Genetically-Engineered Food,
PRESS ASS'N NEWSnLE, Dec. 5, 1996.
108. See Alex Scott, European Protest Surges, CHEMICAL WK., Feb. 5, 1997, at 54.
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price paid for agricultural overuse of chemical fertilizers and
insecticides, and from aggressive agribusiness tactics.'O,
In the face of this deep distrust, a commission of the European Union
(E.U.) recently enacted labeling requirements offering consumers
"comprehensive information on the use of biotechnology in food
products."" This labeling requirement is comprehensive and follows
genetically engineered foods "from farm to table...' Foods that have
been genetically modified will be labeled as such, including the
percentage that has been modified."' This labeling standard, farsighted
in its protection of consumers (particularly in comparison to the FDA's
position), represents a reasonable compromise over much more stringent
proposals to completely segregate genetically engineered foods from
those without any genetically engineered content."3
The distrust of genetically engineered foods is by no means restricted
to Europe. Recent draft standards in Australia and New Zealand require
labeling of any fresh fruits, vegetables or meat that have been genetically
engineered. Further, any processed food containing more than five
percent of a genetically engineered plant or animal would require
labeling."4 This labeling standard, based on proposed E.U. regulations,
would be a far stronger protection of consumer interests than is provided
by current FDA regulations. Still, this draft guideline has been roundly
criticized by both agribusiness and Australian consumer groups as being
an "unacceptable compromise.""'  Whatever the final outcome of this
battle for labeling standards, it is apparent that the FDA is lagging
behind the international trend toward labeling genetically engineered
foods.
Just as a proliferation of individual state labeling standards for
genetically engineered foods would create problems for producers
attempting to ship foods on a national level, so too would a proliferation
of differing national standards create problems for U.S. food exporters in
the global food market. These problems reach beyond relatively simple
economic arguments such as increased packaging costs stemming from
109. See Distrust in Genetically Altered Foods, supra note 10, at 559.
110. EU Gene Label Decision Seen in Need of Follow-Up, REUT NEWS SERv.,
Aug. 4,1997.
I 11. Neil Buckley, EU Wants Labels for Genetically Modified Foodstuffs, FIN.
TiMns (London), Aug. 4, 1997, at 16.
112. See EU Says GMO Guidelines Will Avert U.S. Trade War, RuTERS NEWs
SERV., July 24, 1997.
113. See id.
114. See Australia-New Zealand Transgenic Draft Labeling Standard Sets Labeling
Thresholdfor Processed Food, 5 FOOD LABELUNG NaVs 1 (Feb. 20, 1997).
115. Id.
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different labeling mandates.1 Rather, the existence of differing national
standards presents the possibility of using such standards as trade
barriers designed to protect a local food industry, so-called technical
barriers to trade."7 It is difficult to doubt that a proliferation of standards
presents a potential risk to the $50 billion United States agricultural
export market."' An example of the risk posed by differing national
standards can be seen in the current controversy over exports from the
United States to the E.U. of meat and dairy products from cattle treated
with rBST."9 By blocking any decision on an international standard for
rBST residues in meat and dairy products for the next two years, the
E.U. has effectively blocked the export of these products from the
United States to E.U. countries."2° Unrelated to genetic engineering, but
still emphasizing the ability of differing national standards to disrupt
trade in food, the E.U. has also banned imports of beef products from the
United States based on consumer fears of BSE contamination of United
States herds.' The position of the United States is that any such ban has
"no scientific basis" and will disrupt "billions of dollars in trade."'2
Recognizing that harmonization of international food regulations is a
desirable goal, the United States, together with 150 other countries, is a
member of the Codex Alimentarius Commission, created under the
auspices of the United Nations" with the purpose of developing and
promoting an international set of food standards, including labeling
standards.'2 It should be noted that while member countries are not
obligated to adopt Codex standards,'2' under the Uruguay Round of the
116. See Berselli, supra note 72, at A22.
117. For a detailed discussion of this issue, see John S. Eldred & Shirley A.
Coffield, What Every Food Manufacturer Needs to Know: Realizing the Impact of
Globalization on National Food Regulation, 52 FOoD DRUG COsM. L.J. 31 (1997). U.S.
Agriculture Secretary Dan Glickman has expressed concern that European labeling
requirements may be the equivalent of a non-tarriff trade barrier. See U.S. Opposes EC
Labeling Proposal - Glickman, REUTERS NEWS SERv., Dec. 4, 1997.
118. See Charting U.S. Agricultural Exports: The Long, Hard Road to a New
Record, 7 AGRIC. EXPORTER 14 (1995).
119. See supra note 71.
120. See Codex Delays for Two Years Standards on rBST-Produced Milk and Beef
Products, 39 FOOD CErMIcAL NmVs 27 (1997).
121. See U.S. Decries EU Plan to Ban Imports of its Tallow, REUTERS NMVs SERV.,
Sept. 23, 1997.
122. Id.
123. See Eldred & Coffield, supra note 117, at 31-32.
124. See Degnan, supra note 43, at 57.
125. See Eldred & Coffield, supra note 117, at 33.
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General Agreements on Tariffs and Trade'26 (commonly referred to as
GATT), Codex standards may be relied upon when challenging foreign
standards before the World Trade Organization. 27 For its part, the
United States has the stated goals of enhancing Codex credibility with
regulatory authorities and consumers, and routinely evaluating Codex
standards to serve as the basis for U.S. standards.' 21 In the United States,
the agencies with responsibility for Codex initiatives on food labeling
are the FDA and the Food Safety and Inspection Service, an arm of the
Department of Agriculture 29
The Codex standards for labeling of foods obtained through
biotechnology are currently in an early stage of development.! The
FDA, in position papers concerning Codex labeling standards, argues
that the consumer's right to know should not influence international
standards. 3' Rather, all standards should be based upon sound scientific
and technical information.3 2 Certainly this is a laudable goal, but one
must realize "scientific certainty" is a rare commodity, and this includes
questions of the safety of genetically engineered foods. Rather than
certainty, science provides hypotheses based upon a limited set of data.
Acknowledging the uncertainty inherent in science's understanding of
the safety of genetically engineered foods "does not diminish the
scientific nature of the inquiry."'33 It does, however, provide a rational
basis for governments to err on the side of precaution when developing
standards intended to protect public health." In particular, a case can
certainly be made for labeling of genetically engineered foods based
upon the safety and ecological issues discussed herein.'35 Moreover,
given the levels of distrust in biotechnology present in many countries,
some form of labeling of genetically engineered foods is inevitable. An
126. See Final Act Embodying the Results of the Uruguay Round of Multilateral
Trade Negotiations, Apr. 15, 1994, LEGAL INSTRUMENTS-RESULTS OF THE URUGUAY
ROUNDNO. 1 (1994), 33 I.L.M. 1125 (1994).
127. See Eldred & Coffield, supra note 117, at 34.
128. See OFFICE OF THE U.S. COORDINATOR FOR CODEX ALIMENTARIUs & FOOD
SAFETY & INSPECTION SERV., U.S. CODEX STRATEGIC PLAN (1995).
129. See International Standard-Setting Activities, 62 Fed. Reg. 28,416 (1997).
130. See id. at 28,432 (noting that draft recommendations for labeling such foods
are currently at step three of an eight-step adoption process). See also id. at 28,439-40
(describing the adoption process).
131. See Labeling of Foods and Food Ingredients or Additives Produced Through
Biotechnology, Discussion Document Prepared by the U.S. Delegation to the Codex
Alimentarius Commission, at 6 (1995).
132. See International Harmonization; Policy on Standards, 60 Fed. Reg. 53,078,
53,083 (1995).
133. David A. Wirth, The Role of Science in the Uruguay Round and Nafta Trade
Diciplines, 27 CORNELLINT'LL.J. 817, 837-38 (1994).
134. See id. at 838.
135. See supra Part II.
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international labeling standard, instituted under the Codex, would be
preferable to standards instituted on a nation-by-nation basis. Such an
international labeling standard would go a great distance towards
avoiding the potential trade barriers presented by a proliferation of
differing national standards.
The FDA recognizes three paths to development of an international
standard. These are
(1) The U.S. voluntary standards community or an agency, such as FDA,
develops a U.S. standard and takes it to an international forum so it can be made
an international standard; (2) a standard already developed in an international
forum (or by another country or a regional standards body) is adopted as a U.S.
voluntary or regulatory standard; or (3) a nexy36international standard is
developed "from scratch" in an international forum.
As previously noted, standards for labeling of genetically engineered
foods are already being instituted in a number of countries, together with
an E.U.-wide standard.137 For this reason, the time for developing a
standard de novo has likely passed. Further, given the level of distrust of
biotechnology outside the United States, the current FDA position
regarding labeling (that no per se labeling of genetically engineered food
is necessary)'38 will likely not serve as the basis for an international
standard. By stepping forward with a proposal that provides for labeling
of genetically engineered foods, the FDA can take a position of
leadership in development of an international labeling standard. By
arguing against labeling, the FDA will permit others, particularly the
E.U., to take the lead in development of an international labeling
standard. Any delay in the adoption of international standards can only
harm a major food exporting country like the United States.'39
VII. TOWARDS A REASONABLE STANDARD FOR LABELING OF
GENETICALLY ENGINEERED FOODS
As discussed above,'" the FDA is granted authority to regulate the
136. International Harmonization; Policy on Standards, 60 Fed. Reg. at 53,083.
137. See EU Gene Label Decision Seen in Need of Follow-Up, supra note 108; see
also Australia-New Zealand Transgenic Draft Labeling Standard Sets Labeling
Threshold for Processed Foo, supra note 114.
138. SeesupraPartIV.
139. See Codex Delays for Two Years Standards on rBST-Produced Milk and Beef
Products, supra note 120; U.S. Decries EU Plan to Ban Imports of its Tallow, supra note
121.
140. See supra Part IV.
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food label under the FDCA."4' The FDCA provides a number of
potential avenues for a labeling requirement to be imposed upon
genetically engineered foods through its regulation of misbranded food'42
and information deemed material to the food label. 43 A food is deemed
misbranded if the label does not bear "the common or usual name of the
food" or, if fabricated from two or more ingredients, "the common or
usual name of each."'" Further, an article is deemed misbranded if the
label "fails to reveal facts material... with respect to consequences
which may result from the use of the articles to which the labeling or
advertising relates .... under such conditions of use as are customary or
usual." .45  FDA guidelines indicate that, under these standards,
consumers must be notified through appropriate labeling if a genetically
engineered food "differs from its traditional counterpart such that the
common or usual name no longer applies to the new food, or if a safety
or usage issue exists to which consumers must be alerted."' 46 Currently
the FDA applies these standards narrowly, with the goal of not over-
labeling products and thereby reducing the overall effectiveness of such
labels.
The goal of not over-labeling products is certainly an important one.
Information contained on the food label must be limited in volume and
complexity so as not to overwhelm the consumer and diminish the
impact of information critical to an informed choice. In its 1992 policy
statement, the FDA said it "was not aware of any information to suggest
that the application of recombinant DNA techniques... to the
development of new plant varieties would result in foods which, as a
class, exhibit attributes different from foods derived from other methods
of plant breeding."' 48 If such a statement were true, the FDA goal of
limiting the information present in food labels would indeed call for no
labeling of genetically engineered foods. But, due to the ability to
overcome genetic barriers and produce novel foods, recombinant DNA
techniques present a quantum leap over traditional plant breeding
techniques. Current research 149 points out the potential risks inherent to
these novel foods. The potential health effects of consuming genetically
141. See 21 U.S.C. §§ 321, 343 (1994).
142. See id. § 343(i).
143. See id. § 321(n).
144. Id. § 343(i).
145. Id. § 321(n).
146. Statement of Policy: Foods Derived From New Plant Varieties, 57 Fed. Reg.
22,984, 22,991 (1992).
147. See Degnan, supra note 43, at 52.
148. Food Labeling; Foods Derived from New Plant Varieties, 58 Fed. Reg. 25,837,
25,838 (1993).
149. See supra Part H1.
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engineered foods, the inability to effectively test for allergenic and
toxicological potential of such foods, and the inability of consumers to
identify such foods in the marketplace so that they might avoid certain
ingredients, give the FDA sufficient reasons to find the use of genetic
engineering techniques to be a material fact under the FDCA,'150 and thus
give the FDA statutory authority to mandate labeling of genetically
engineered foods.
In a request for information from all parties interested in the FDA's
stand on labeling genetically engineered foods, the FDA posed a number
of questions which indicate the direction such a labeling standard might
take.' It is appropriate to answer several of these questions here. First,
"[h]ow should 'genetic engineering' be defined?"'52 Genetic engineering
should be defined broadly as this will likely be the initial step in
determining whether a food should be labeled. So, in addition to
recombinant DNA techniques, genetic engineering should include any
technique that allows the production of a transgenic plant or animal.'
Under this broad definition, genetic engineering would include cell or
protoplast fusion techniques," for example.
Next, the FDA asked what is perhaps the key question for any labeling
standard-that is, "[w]hat specific characteristics of foods derived from
'genetically engineered' plants distinguish such foods from other foods,
and thus, such foods might warrant special labeling? Are there foods
derived from genetically engineered plants without such characteristics
and, thus, would not warrant labeling disclosing the method of
production on the food?"'' 5  The FDA describes six possible
modifications that might distinguish genetically engineered foods, such
that labeling might be appropriate. These are: (1) foods modified to
contain proteins not previously found in food, even if present in minute
150. See 21 U.S.C. § 321(n).
151. See Food Labeling; Foods Derived from New Plant Varieties, 58 Fed. Reg.
25,837, 25,839-41 (1993).
152. 1d. at 25,839.
153. See ANIMALS WrrH NOVEL GENES, supra note 17; GENEc IMPROVEMENTS OF
AGRICULTURALLY IMPORTANT CROPS, supra note 17.
154. In cell fusion techniques, two cells are induced to merge, forming a new cell
containing the genetic material of both donor cells. Protoplast fusion involves removing
the cell wall of a plant cell, forming what is known as a "protoplast", prior to cell fusion.
See James F. Shepard et al., Genetic Transfer in Plants Through Interspecific Protoplast
Fusion, 219 SCIENCE 683 (1983).
155. Food Labeling; Foods Derived from New Plant Varieties, 58 Fed. Reg. 25,837,
25,839 (1993).
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quantities; (2) foods modified to contain proteins new to a particular
food, but present in other foods; (3) foods modified to contain a higher
(or lower) concentration of a protein native to that food; (4) foods
modified to contain new, but unexpressed, DNA; (5) foods modified to
exhibit improved nutrition or handling characteristics; and (6) food
ingredients (e.g. vegetable oil or food starch) that are unchanged
because, although the plant or animal was modified, no new substances
are introduced into the ingredient itself.
156
With regard to the current narrow FDA position on labeling, it has
been noted that "the FDA will be looking at the nucleic acid sequences
effects on the composition of the food product rather than the DNA
itself." 57 This statement must apply to any broader labeling standard as
well, for it is not the addition of DNA by genetic engineering itself
which should trigger a label. Instead, it is the resulting expression of the
new DNA that must be the focus of a labeling requirement. Thus, any
genetic engineering that unexpectedly changes the composition of a food
in a manner that might present a health risk to a susceptible population
should be labeled. By this measure, the first FDA modification, perhaps
pointed at antibiotic resistance genes used as markers,'58 would require
labeling, because the presence of the resistance protein would be wholly
unexpected by the consumer. As discussed, even in trace amounts such
a protein may present substantial risks that bear on a consumer's
informed choice. 9 Also the second FDA modification perhaps dealing
with Brazil nut proteins inserted into soybeans," ° would require labeling
under the same reasoning. Such labeling should include the identity of
the novel protein. The third FDA modification, which increases the
concentration of an existing constituent of the food, would trigger a
labeling requirement because this could increase the concentration of an
allergen or toxicant to a level that becomes significant to a susceptible
population.
Conversely, genetic modifications that do not affect consumers'
expectation for composition of the food would not trigger a labeling
requirement. Thus, the third FDA modification, which merely decreases
the concentration of a previously existing constituent of the food, would
not require labeling since the reduced presence of the constituent would
not be expected to cause any reaction to a susceptible population.,'
156. See id.
157. Bohrer, supra note 35, at 660.
158. See id. at 673-74.
159. See supra Part I.
160. See Nordlee, supra note 22.
161. Note that the FDA still must require labeling if the altered level of a previously
existing constituent resulted in significant change to the nutrient value or safety of the
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Also, the fourth FDA modification would merely introduce DNA, a
normal constituent of all plants and animals, to a food, and therefore not
change the expected composition of that food. Finally, modifications
number five and six, because they do not result in new substances in the
final food or ingredient, would not require labeling.' 62
Another concern is the form of the food in question, i.e., "is labeling
appropriate for both fresh produce, processed foods, or both?"' 163 The
answer is that both types of foods should be labeled if they meet the
labeling criteria as defined above. This is a similar issue to that posed
during the debate over the labeling of irradiated foods. 4 In that case,
the FDA required labeling of unprocessed foods, reasoning that
irradiation could cause changes in the properties of such foods.
Consumers might assume such food was not processed in this manner,
so irradiation was deemed a material fact. In contrast, individual
ingredients that had been irradiated prior to inclusion in processed foods
required no labeling, as consumers would recognize that such foods had
been processed. Such ingredients were only to be declared by their
common name.65  In the case of genetically engineered foods,
consumers will assume that soybeans are soybeans, whether fresh or in
processed foods. The presence of something akin to a Brazil nut protein
will not be anticipated simply because a food is processed, assuming
Brazil nut is not either listed as an ingredient or as being present via
genetic engineering.
A question related to the form of the food is, what labeling should be
required "for a food derived from a plant that contains multiple traits that
originated from different lines" or "for plant cultivars developed by
traditional techniques... when one (or both) parent line(s) is developed
from a progenitor line that was developed using 'genetic engineering'
food, by employing current FDCA standards. See Statement of Policy: Foods Derived
From New Plant Varieties, 57 Fed. Reg. 22,984, 22,993 (1992).
162. It should be noted that any exemption from a requirement for labeling
presumes that no marker proteins (e.g., antibiotic resistance proteins) are contained in the
food.
163. See Statement of Policy: Foods Derived From New Plant Varieties, 57 Fed.
Reg. 22,984, 22,993 (1992).
164. See Irradiation in the Production, Processing, and Handling of Food, 21 C.F.R.
§ 179 (1997). See also Irradiation in the Production, Processing, and Handling of Food,
51 Fed. Reg. 13,376 (1986); Irradiation in the Production, Processing, and Handling of
Food, 53 Fed. Reg. 53,176 (1988).
165. See Irradiation in the Production, Processing, and Handling of Food, 53 Fed.
Reg. 53,176, 53,205 (1988).
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techniques."' '  Again, labeling would be required whenever genetic
engineering unexpectedly changes the composition of a food in a manner
that might present a health risk to a susceptible population. For
example, a cultivar resulting from the breeding of a transgenic soybean
parent with a traditional parent would require labeling if the cultivar
contained the Brazil nut protein or antibiotic resistance protein of the
transgenic parent.
The FDA is also concerned with the circumstances when labeling
would be appropriate given that, for example, "most commercially
produced tomatoes have introduced genetic traits derived from related
weedy species."' 67  Specifically, the FDA asks if there is a basis in
science to differentiate between genes added by genetic engineering
techniques and those added by traditional breeding techniques." As
previously noted, few modem agricultural products can escape being
described as "genetically modified.', 9  The prototypical educated
consumer must assume that a modem grocery store tomato contains
genes derived from a number of closely related species. As noted,
traditional genetic manipulation does not present the risk of surprise in a
food's composition presented by genetic engineering. Thus, labeling
becomes appropriate because genetic engineering is used to reach
beyond these closely related species.
Finally, the FDA has noted the logistical difficulties with "labeling
foods derived from 'genetically engineered' commodities (such as wheat
or corn) at every stage of the food chain which extends from the farm to
the grocery store."'' Specifically, the FDA questions the feasibility and
costs of such an effort.'' In terms of feasibility, there is one U.S.
company developing the technology to detect the presence of genetically
modified foods.' Current technology has the ability to identify
genetically engineered corn at a level of one part in 10,000."3 Given the
intense interest in such detection, particularly in Europe, the pace of
innovation in this regard will likely continue to accelerate. The ability to
test foods for genetic modification will provide the feasibility to monitor
166. Food Labeling; Foods Derived from New Plant Varieties, 58 Fed. Reg. 25,837,
25,839-40 (1993).
167. Id. at 25,840.
168. See id.
169. See supra Part ll.
170. Food Labeling; Foods Derived from New Plant Varieties, 58 Fed. Reg. 25,837,
25,840 (1993).
171. See id.
172. See Testing of Genetically-Modified Foods Accelerates Through U.S.-
European Technology Collaboration, PR Nawswim, Dec. 17, 1996.
173. Anne Scott, Frankenfood? Superweeds? Or just another day in the lab?, 93
BusiNEss REcORD-DEs MOINES, IA 12 (1997).
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compliance with any labeling standard.
In terms of cost, there is little doubt there is some cost to any labeling
effort. Infrastructure must be put into place for necessary record keeping
and monitoring. Further, segregation into separate genetically
engineered and non-genetically engineered pools will increase handling
costs for food. For example, agricultural commodities that have been
segregated by virtue of being free of genetic engineering currently cost
as much as sixty-five cents more per bushel in Europe than do
unsegregated commodities.174 This calls attention to the fact there is a
market ready to demand food free of biotechnical advances and willing
to pay for the privilege.75 Further, this emphasizes that the costs of
labeling genetically engineered foods are inevitable, at least in the world
market." Such costs will further escalate given labeling initiatives in
individual states.'
In short, the feasibility and costs of such an effort are irrelevant.
Labeling of genetically engineered foods is becoming a fact, and the
costs will be borne by the consumer. The concern must turn from
avoiding these costs to minimizing them. The best method for
minimizing the costs of this labeling will be to avoid a proliferation of
labeling standards through promulgation of a U.S. national standard
which preempts individual state action, and for the FDA to provide
leadership towards harmonization at the international level.
VIII. CONCLUSION
It is not doubted that genetic engineering will remain a key tool in the
effort to produce a more abundant and nutritious food supply, and it is
not argued here that the benefits of genetic engineering of foods do not
far outweigh the inherent risks. However, given the level of risk
174. See GMO-free Soybeans to Cost EU 15 pct More-Expert, REUTERs NEWS
SERV., Sept. 25, 1997 (discussing costs of segregating and testing soybeans to be
certified free of genetically modified organisms). See also Scott, supra note 173 (noting
this cost applies to corn as well as soybeans).
175. At least one company has pledged to fill this demand. Morris Tabaksblat,
chairman of the Dutch division of Unilever, recognizing that "if we fail to respect
consumers' views, we should not be doing our jobs properly," pledged that Unilever
would find non-genetically engineered foods for those consumers who wish to buy them.
Christopher Lyddon, Unilever Says Gene Food is Weapon Against Hunger, RETRs
NEws SERv., Oct. 16, 1997.
176. See supra Part V.
177. See supra Part IV.
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presented by these novel foods, a labeling requirement for genetically
engineered foods is certainly scientifically justifiable. The potential
health risks of genetically engineered foods provide the FDA with the
necessary statutory authority to mandate labeling under the FDCA.
Beyond the question of protecting public health, labeling of genetically
engineered foods is necessary to develop public confidence in these
novel foods. Finally, by reconsidering its stand on labeling genetically
engineered foods, the FDA can provide both a single national labeling
standard and provide leadership in the development of a single
international labeling standard.
MICHAEL A. WHrTAKER
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